Literature DB >> 21216305

Epiplakin1 is expressed in the cholangiocyte lineage cells in normal liver and adult progenitor cells in injured liver.

Akira Matsuo1, Tetsu Yoshida, Takanori Yasukawa, Rika Miki, Kazuhiko Kume, Shoen Kume.   

Abstract

We have previously identified Epiplakin1 (Eppk1) as a gene expressed in pancreatic progenitor cells. Here we studied the expression of Eppk1 in developing and regenerating livers in mice. Eppk1 is initially expressed in the early bipotential hepatoblasts and is later confined to the cholangiocytes. After birth, Eppk1 is expressed in the bile duct. In the livers of mice fed with a choline-deficient ethionine-supplemented (CDE) diet, Eppk1-positive cells dramatically increase in number. The Eppk1-positive cells express A6, thereby indicating that they are hepatic progenitor cells. Other cholangiocyte markers, such as Cytokeratins, E-cadherin, osteopontin and Sox9, are also co-expressed in the hepatic progenitor cells. Some of the Eppk1-positive cells express PCNA, a proliferation marker, thereby suggesting their identities as transient amplifying cells. In conclusion, we have shown that Eppk1 serves as a useful marker for detecting the hepatic progenitor population in the developing and adult liver. The use of Eppk1 as a marker will facilitate studies of mouse hepatic progenitor cells.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21216305     DOI: 10.1016/j.gep.2011.01.001

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  7 in total

1.  New insight into reactive ductular cells of biliary atresia provided by pathological assessment of SOX9.

Authors:  Hiroko Suda; Daiki Yoshii; Kenichi Yamamura; Yuji Yokouchi; Yukihiro Inomata
Journal:  Pediatr Surg Int       Date:  2014-05       Impact factor: 1.827

2.  Prevalence of Aflatoxin-Associated TP53R249S Mutation in Hepatocellular Carcinoma in Hispanics in South Texas.

Authors:  Jingjing Jiao; Weibo Niu; Ying Wang; Keith Baggerly; Yuanqing Ye; Xifeng Wu; Dewitt Davenport; Jose Luis Almeda; Monica M Betancourt-Garcia; R Armour Forse; Heather L Stevenson; Gordon P Watt; Joseph B McCormick; Susan P Fisher-Hoch; Laura Beretta
Journal:  Cancer Prev Res (Phila)       Date:  2017-10-31

3.  Embryonic ductal plate cells give rise to cholangiocytes, periportal hepatocytes, and adult liver progenitor cells.

Authors:  Rodolphe Carpentier; Regina Español Suñer; Noémi van Hul; Janel L Kopp; Jean-Bernard Beaudry; Sabine Cordi; Aline Antoniou; Peggy Raynaud; Sébastien Lepreux; Patrick Jacquemin; Isabelle A Leclercq; Maike Sander; Frédéric P Lemaigre
Journal:  Gastroenterology       Date:  2011-06-25       Impact factor: 22.682

4.  Kupffer cells influence parenchymal invasion and phenotypic orientation, but not the proliferation, of liver progenitor cells in a murine model of liver injury.

Authors:  Noémi Van Hul; Nicolas Lanthier; Regina Español Suñer; Jorge Abarca Quinones; Nico van Rooijen; Isabelle Leclercq
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

5.  Epiplakin attenuates experimental mouse liver injury by chaperoning keratin reorganization.

Authors:  Sandra Szabo; Karl L Wögenstein; Christoph H Österreicher; Nurdan Guldiken; Yu Chen; Carina Doler; Gerhard Wiche; Peter Boor; Johannes Haybaeck; Pavel Strnad; Peter Fuchs
Journal:  J Hepatol       Date:  2015-01-21       Impact factor: 25.083

6.  Epiplakin deficiency aggravates murine caerulein-induced acute pancreatitis and favors the formation of acinar keratin granules.

Authors:  Karl L Wögenstein; Sandra Szabo; Mariia Lunova; Gerhard Wiche; Johannes Haybaeck; Pavel Strnad; Peter Boor; Martin Wagner; Peter Fuchs
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

7.  KLF5-mediated Eppk1 expression promotes cell proliferation in cervical cancer via the p38 signaling pathway.

Authors:  Dong Ma; Zhe Pan; Quan Chang; Jin-Jin Zhang; Xiao Liu; Na Hua; Guo-Hua Li
Journal:  BMC Cancer       Date:  2021-04-08       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.